CBFb-SMMHC is expressed from the inv(16) chromosome in M4Eo AML. Mice lacking CBF subunits or expressing the CBFb-SMMHC or AML1-ETO oncoproteins failed to develop de®nitive hematopoiesis. To investigate these eects on hematopoiesis, we expressed CBFb-SMMHC from the metallothionein promoter, in both 32D cl3 myeloid cells and Ba/F3 B-lymphoid cells. Addition of zinc increased CBFb-SMMHC levels more than tenfold, with higher levels evident in Ba/F3 lines. Levels obtained in 32D cl3 cells were similar to those of endogenous CBFb. Indirect immuno¯uorescence revealed zinc-inducible speckled, nuclear staining in Ba/F3 cells and diuse nuclear staining in 32D cl3 cells. CBFb-SMMHC reduced endogenous CBF DNA-binding ®vefold in both cell types, increased cell generation time 1.9-fold, on average, in 32D cl3 cells and 1.5-fold in Ba/ F3 cells and decreased tritiated thymidine incorporation into DNA correspondingly. CBFb-SMMHC increased the proportion of cells in G1 1.7-fold, on average, in 32D cl3 and Ba/F3 cells, and decreased the proportion of cells in S phase by a similar degree. CBFb-SMMHC induced a marked increase in hypophosphorylated Rb, but did not alter IL-3 Receptor a or b subunit levels. Neither apoptosis nor 32D dierentiation was induced by zinc in IL-3 in these lines. Induction of CBFb-SMMHC in 32D cl3 cells did not inhibit their dierentiation to neutrophils or their expression of myeloperoxidase mRNA in G-CSF, and did not produce an eosinophilic phenotype. Additional, proliferative genetic changes in M4eo AMLs might potentiate inhibition of dierentiation by CBFb-SMMHC by allowing its increased expression.
Introduction
Characteristic chromosomal abnormalities, inv(16) (p13q22) or less commonly t(16;16)(p13q22), are present in virtually all cases of the FAB M4eo subtype of acute myeloid leukemia (AML) (Arthur and Bloom®eld, 1983; Le Beau et al., 1983) . This subset of AML is associated with eosinophilic blasts, which themselves carry the inv(16) chromosome (Haferlach et al., 1996) . These abnormal chromosomes contain a fusion gene, CBFB-MYH11, which encodes a fusion protein, CBFb-SMMHC, in which the majority of the CBFb coding sequences are fused to those encoding the tail domain of a smooth muscle myosin heavy chain (SMMHC, Liu et al., 1993) . We have detected the CBFb-SMMHC fusion oncoprotein in leukemic blasts from patients with M4eo AML . Several variant CBFB-MYH11 fusion mRNAs have been detected in patient samples (Liu et al., 1993; Claxton et al., 1994; Shurtle et al., 1995) . The most common fusion mRNA encodes the majority of CBFb, save the C-terminal 17 amino acids, and the C-terminal 412 amino acids of SMMHC.
Core binding Factor (CBF), also known as PEBP2, is a family of heterodimeric transcription factors consisting of a common b subunit, CBFb, and unique a subunits, CBFa1, AML1 (CBFa2), and CBFa3 (Kamachi et al., 1990; Wang and Speck, 1992; Satake et al., 1992; Bae et al., 1993; Ogawa et al., 1993a,b; Wang et al., 1993; Levanon et al., 1994) . CBFb does not bind DNA directly, but increases the anities of the CBFa (PEBP2a) subunits for DNA (Ogawa et al., 1993b; Wang et al., 1993) . The CBFa subunits contain a Runt-homology domain required for DNA binding and for heterodimerization (Meyers et al., 1993; Ogawa et al., 1993a) .
The importance of the CBFs for hematopoiesis is evident from the observation that mice lacking AML1 or CBFb failed to develop de®nitive hematopoiesis, including lymphopoiesis and died in utero (Okuda et al., 1996a; Wang et al., 1996a,b) . CBFs regulate both lymphoid and myeloid genes, including those encoding TCRd, IL-3, myeloperoxidase (MPO), neutrophil elastase, and the M-CSF Receptor (Redondo et al., 1992; Cameron et al., 1994; Suzow and Friedman, 1993; Nuchprayoon et al., 1994; Zhang et al, 1994) .
We have provided evidence that CBFb-SMMHC can sequester CBFa subunits into non-functional complexes . The gene encoding AML1 is present at the breakpoint of t(8;21) (q22;q22), present in blasts of some patients with FAB M2 AML (Miyoshi et al., 1991) . These blasts contain a fusion protein AML1-ETO, which includes the DNA-binding domain of AML1 (Erickson et al., 1992; Nisson et al., 1992; Miyoshi et al., 1993; Sacchi et al., 1996) . AML1-ETO is capable of acting as a transcriptional repressor Frank et al., 1995) . In t(3;21)(q26;q22) AML1 is fused to additional partners which are also capable of interfering with transactivation by AML1 (Zent et al., 1996) . Truncated AML1 proteins, containing only the DNAbinding domain, also interfere with CBF function (Tanaka et al., 1995; Britos-Bray et al., 1996) and might contribute to AML associated with t(8;21) or t(3;21) (Nucifora et al., 1993; Mitani et al., 1994; Sacchi et al., 1994; Tighe and Calabi, 1994) . Pediatric B-lineage acute lymphocytic leukemia (ALL) often harbors t(12;21), encoding a TEL-AML1 fusion protein (Golub et al., 1995; Romana et al., 1995) , which also interferes with AML1 transactivation .
Mice in which the CBFb-SMMHC or AML1-ETO cDNAs had been`knocked-in' to their normal loci failed to develop de®nitive hematopoiesis and died in utero (Castilla et al., 1996; Okuda et al., 1996b; Yergeau et al., 1997) . These phenotypes are identical to that of AML1 and CBFb null mice, providing additional evidence that these oncoproteins act by inhibiting CBF functions. To investigate the basis for the lack of hematopoiesis in CBF null mice and in CBF-oncoprotein`knock-in' mice, we have examined the eect of expressing CBFb-SMMHC from the zincinducible sheep metallothionein (MT) promoter in 32D cl3 myeloid cells and in Ba/F3 B-lymphoid cells.
Zinc-inducible CBFb-SMMHC expression was obtained in both cell lines, although higher levels were evident in Ba/F3 cells. Indirect immuno¯uorescence revealed that at higher levels, CBFb-SMMHC can form small speckled and rod-like nuclear particles, as previously observed in NIH3T3 cells and in patient samples Liu et al., 1996) . Induction of CBFb-SMMHC decreased endogenous CBF DNA-binding, as previously described , and slowed the rates of cell proliferation in both cell lines, but did not induce apoptosis or differentiation. Cell cycle analysis demonstrated that 32D cl3 and Ba/F3 cells had, on average, a 1.7-fold increase in G1 phase cells, and a similar decrease in the proportion of S phase cells. The G1/S ratio increased nearly threefold. Western blotting demonstrated that induction of CBFb-SMMHC led to a marked increase in the proportion of retinoblastoma (Rb) protein in the hypophosphorylated form. These ®ndings indicate that CBFb-SMMHC inhibits the G1 to S cell cycle transition at or prior to the restriction point via inhibition of CBF DNA binding in both myeloid and lymphoid cells.
32D cl3 cells expressing CBFb-SMMHC differentiated to neutrophils, induced myeloperoxidase mRNA in the presence of G-CSF, and did not develop an eosinophilic phenotype. Our ®ndings indicate that additional genetic changes are present in M4Eo AML cells which by-pass the eect of CBFb-SMMHC on cell cycle progression. In this setting, CBFb-SMMHC might inhibit CBF function more completely and so more eectively slow their myeloid dierentation.
Results

Conditional expression of CBFb-SMMHC in 32D cl3 and Ba/F3 cells
In initial experiments we transduced 32D cl3 cells with a retroviral vector encoding CBFb-SMMHC or a control vector. A toxic eect was evident, as colonies transduced with the vector encoding CBFb-SMMHC were smaller than control colonies. Only 11 of 48 subclones examined expressing detectable protein on Western blotting. Several of these clones proliferated at a slower rate than control clones and were dicult to maintain in culture and data not shown).
To assist investigation of CBFb-SMMHC functions we therefore sought to express this protein from the zinc-responsive sheep metallothionein (MT) promoter. The 1.8 kb CBFb-SMMHC cDNA was positioned downstream of the MT promoter in pMTCB6 to generate pMTINV. We ®rst transfected pMTCB6 or pMTINV into Ba/F3 cells and obtained pools of neomycin-resistant cells. Expression levels of CBFb-SMMHC in pooled Ba/F3-MTINV cells and in three Ba/F3-MTINV subclones at various times after addition of zinc were determined by Western blotting after electrophoresis on 8% acrylamide gels (Figure 1a and b). Basal expression of CBFb-SMMHC was detectable, and addition of zinc induced its expression 5 ± 10-fold by 7 h.
The pMTCB6 and pMTINV plasmids were also transfected into 32D cl3 cells and clonal lines were obtained by limiting dilution. Whereas all of the Ba/ F3-MTINV subclones examined expressed similar high levels of CBFb-SMMHC, zinc-inducible expression was only evident in half of the 32D cl3 lines examined. The expression of CBFb-SMMHC in three of these lines was compared to that of a Ba/F3-MTINV line after electrophoresis on a 10% acrylamide gel (Figure 1c ). CBFb-SMMHC expression was induced markedly in response to zinc in all three 32D-MTINV lines, although the maximal levels obtained were several-fold less than that obtained in Ba/F3-MTINV cells. Immunoreactive material at 59 kd (*) likely represents partial degradation of CBFb-SMMHC occurring during extract preparation. A shorter exposure of the autoradiograph demonstrated that this material was present at about tenfold lower levels than full-length protein in the Ba/F3 INV-3 extract (data not shown). Use of a 10%, rather than an 8%, acrylamide gel allowed retention and detection of immunoreactive material at 23 kd, which represents endogenous CBFb (Ogawa et al., 1993b; Wang et al., 1993) . For most of the paired samples, CBFb levels were not aected by zinc addition. CBFb-SMMHC levels in the 32D-MTINV-2 and -3 lines were similar to those of endogenous CBFb.
Zinc-inducible speckled nuclear CBFb-SMMHC expression
Ba/F3-MTCB6 and -MTINV-3 cells were cytospun, ®xed, stained with anti-CBFb antiserum, and subject to indirect immuno¯uorescence (Figure 2a ). MTCB6 cells did not stain with the antiserum. A low level of diuse nuclear staining was evident prior to zinc addition in the MTINV-3 cells whereas a dramatic speckled nuclear staining pattern was evident 1 day after zinc addition in about 50% of the cells, as previously described in M4Eo AML cells . Small nuclear rod-like structures were evident in some cells. A rare cell demonstrated very large nuclear rod-like structures (data not shown), as described previously in NIH3T3 cells . The development of speckled or rod-like nuclear structures was dependent on CBFb-SMMHC expression levels. This observation supports the model that these structures develop as a rseult of CBFb-SMMHC oligomerization. When 32D-MTINV-1 or -3 cells were stained similarly, a modest increase in diuse nuclear staining was evident in the presence of zinc (Figure 2b ). When 32D-MTCB6 cells were subject to the same procedure, a low level of nuclear staining was detected, similar to the MTINV lines prior to zinc addition, and these cells did not stain with secondary antibody alone (data not shown). Lack of a speckled pattern in the nuclei of the 32D-MTINV lines may re¯ect both higher non-speci®c staining and the lower CBFb-SMMHC expression levels in 32D-MTINV cells, compared with Ba/F3-MTINV cells.
CBFb-SMMHC inhibited CBF DNA-binding in Ba/F3 and 32D cl3 cells Nuclear extracts were prepared from Ba/F3, from Ba/ F3-MTCB6, and from three Ba/F3-MTINV subclones, at 0 and 24 h after zinc addition. Equal amounts of these extracts, as quanti®ed by mini-Bradford assay, were incubated with a radiolabeled CBF-binding site derived from the MPO promoter (Suzow and Friedman, 1993 ), and the reactions were then resolved on an acrylamide gel ( Figure 3a ). Even prior to zinc addition, Ba/F3-MTINV-1 and -2 cells had a 2 ± 3-fold reduction in CBF DNA-binding activities, which might also re¯ect clonal variation in CBF activities. Addition of zinc led to a marked additional reduction in CBF DNA-binding activity, whereas this activity was unaected in the control extracts. The speci®city of CBF DNA-binding was veri®ed by competition with a wild-type oligonucleotide and an oligonucleotide containing point mutations in the CBF-binding site ( Figure 3b ). This autoradiograph was exposed for a longer time than that of Figure 3a , and so demonstrates that induction of CBFb-SMMHC reduced CBF DNA-binding in extracts from MTINV-1 cells approximately ®vefold. In contrast, expression of two non-speci®c gel shift species, one above and one below the CBF band, were nearly unchanged. A speci®c complex of low mobility was also more evident on this longer exposure (*), which may result from multimerization of CBFb-SMMHC via the SMMHC domain (Kiehart, 1990) , binding of CBFa to these multimers, and DNA-binding by these larger complexes.
Equivalent amounts of extract from 32D cl3 cells, 32D-MTCB6 cells, and 32D-MTINV subclones were also incubated with the radiolabeled CBF-binding site and subject to EMSA (Figure 3c ). Prior to zinc addition, CBF DNA-binding activities were similar in these extracts. Addition of zinc did not alter these activities in control extracts, but reduced endogenous CBF DNA-binding 3 ± 5-fold (left panel). Speci®city of CBF DNA-binding was again veri®ed by oligonucleotide competition (right panel), and equivalency of the extracts was con®rmed by EMSA with a USF-binding site (data not shown), as described (Suzow and Friedman, 1993) . The 32D-MTINV extracts, like the Ba/F3-MTINV extracts, contained a complex of very low mobility, which, remarkably, was not detected in the control extracts and which bound the CBF site (*). Of note, the amount of this complex did not increase markedly with zinc, despite tenfold induction of CBFb-SMMHC protein expression. This observation may indicate that once induced CBFb-SMMHC is in vast excess to endogenous CBFa subunits. Also, a portion of CBFa bound to CBFb-SMMHC`rods' might be insoluble under our extraction conditions. CBFb-SMMHC slowed the proliferation of Ba/F3 and 32D cl3 cells
The proliferation rates of the control and INV lines were similar in the absence of zinc (data not shown). We seeded Ba/F3-MTCB6 and Ba/F3-INV cells at 2610 4 cells/ml in the presence and absence of zinc and enumerated viable cells over time using a hemocytometer ( Figure 4a , left panel). Addition of zinc speci®cally slowed the growth rates of the Ba/F3-MTINV subclones, increasing their generation times 1.5-fold, from 9.6 to 14.4 h, on average. The growth rates of 32D cl3, 32D-MTCB6, and 32D-MTINV cells were also compared in the presence and absence of zinc ( Figure 4b , left panel). As control 32D cl3 cells proliferated at a slower rate than Ba/F3 cells, we were able to collect data for an additional day before they reached saturation density. Addition of zinc slowed the growth of the 32D-INV subclones, increasing their generation times by 1.6 ± 2.1-fold, from 13.1 h in the absence of zinc, but did not aect the growth rate of the control cells. The morphology of these 32D-INV subclones, as assessed by Wright'sGiemsa staining was not altered by the presence of zinc over a 4 day period, whereas 32D cl3 cells cultured in G-CSF during this period dierentiated into mature neutrophils.
To further compare the proliferation rates of these cell lines, each was cultured either in the presence or absence of zinc and exposed to tritiated thymidine for 18 h, beginning 0, 24, or 48 h after zinc addition. CBFb-SMMHC induction did not alter DNA synthesis rates in the Ba/F3-MTCB6 cells, but decreased DNA synthesis 50 ± 80% in the Ba/F3-MTINV lines during the second day (h 24 ± 42) after zinc addition ( Figure  4a , right panel). The inhibition of tritiated thymidine incorporation into the Ba/F3-MTINV lines was more pronounced during day 2 (h 24 ± 42) compared with day 1 (h 0 ± 18), re¯ecting the reduction in cell accumulation already present as a result of the initial 24 h period of zinc. Induction of CBFb-SMMHC reduced the DNA synthesis rates of the 32D cl3 and 32D-MTCB6 cells 1.3-fold and of the 32D-MTINV lines 2.5 ± 4-fold during the second and third days (h 24 ± 42 and 48 ± 66) after zinc addition (Figure 4b , right panel). Consistent with these results, in clonogenic assays zinc did not aect colonies obtained from MTCB6 lines, but reduced the colony yield from MTINV lines threefold and markedly reduced colony size (not shown).
CBFb-SMMHC did not inhibit 32D cl3 cell dierentiation
Although zinc did not aect 32D cl3 or 32D-MTCB6 cell proliferation in IL-3, addition of zinc to these cells in G-CSF slowed their rate of cell accumulation by almost twofold during a 72 h period and increased their rates of granulocytic dierentiation. When the 32D-MTINV subclones were cultured similarly, addition of zinc slowed their growth rates 2 ± 3-fold during a 72 h period, and these lines dierentiated to neutrophils with a rate similar to the control lines cultured in zinc (Figure 5a ). MPO mRNA levels were assessed daily in cultures of 32D-MTINV-3 cells transfered to G-CSF in the presence or absence of zinc (Figure 5b ). Induction of CBFb-SMMHC did not inhibit MPO mRNA induction, consistent with its lack of eect on morphologic granulocytic dierentiation.
Also, expression of CBFb-SMMHC did not render 32D cl3 or Ba/F3 cells IL-3-independent, as both the 32D-MTINV and Ba/F3-MTINV lines underwent apoptosis at similar rates upon IL-3 withdrawal in Figure 3 CBFb-SMMHC inhibits CBF DNA-binding activity in Ba/F3 and in 32D cl3 cells and forms a multimeric nuclear complex. (a) Nuclear extracts were prepared from Ba/F3, Ba/F3-MTCB6, and Ba/F3-MTINV-1, -2, and -3 cells 0 or 24 h after addition of zinc. 12 mg of nuclear protein from each extract was incubated with a radio-labeled 32 bp oligonucleotide which was derived from the MPO promoter and contains a site known to bind CBF (Suzow and Friedman, 1993) . After 30 min on ice, bound proteins were visualized by electrophoresis on a 5% acrylamide gel followed by autoradiography. The position of bound CBF is indicated. (b) To verify the speci®city of binding, the 24 h Ba/F3-MTINV-1 extract was subject to EMSA with the MPO oligonucleotide without competitor, in the presence of 50-fold excess of unlabeled wild-type oligonucleotide (W), or in the presence of 50-fold excess of an unlabeled mutant oligonucleotide containing point mutations in the CBF-binding site (M). For comparison, the 0 h MTINV-1 extract was included without competition. The positions of CBF (arrow) and a low mobility complex (*) are indicated. (c) Nuclear extracts were prepared from 32D cl3, 32D-MTCB6, and 32D-MTINV-1, -2, and -3 cells 0 or 24 h after zinc addition and subject to EMSA similarly (left panel). The 0 h 32D-MTINV-3 extract was also incubated in the presence of 50-fold excess of the wild-type or mutant CBF oligonucleotide prior to EMSA (right panel). The positions of CBF and a low mobility complex are indicated (*) 
CBFb-SMMHC slowed the G1 to S cell cycle transition
Addition of zinc did not lead to evident cell death in the Ba/F3-MTINV or 32D-MTINV lines. To further assess apoptosis and to quantitate cell cycle parameters in these subclones and the corresponding control populations, the cells were cultured with or without zinc for 18 h and then exposed to BrdU for 30 min. The cells were then ®xed, stained with anti-BrdU-FITC and propidium iodide (PI), and subject to FACScan analysis. This analysis revealed that 1/3 of the 32D cl3 parental cell population was tetraploid, as was the 32D-MTINV-1 subclone. Therefore, six diploid 32D-MTCB6 subclones were isolated by limiting dilution from the 32D-MTCB6 pooled population to serve as control lines. Representative analyses, for 32D-MTCB6-1, 32D-MTINV-1, and 32D-MTINV-3 cells a b Figure 4 CBFb-SMMHC inhibits proliferation of Ba/F3 and 32D cl3 cells. (a) Ba/F3-MTCB6, Ba/F3-MTINV-1, -2, and -3 cells were seeded at 2610 4 cells/ml in the presence or absence of zinc. Viable cell numbers were then enumerated daily. The increases in cell number after 1 or 2 days in the presence of zinc relative to the absence of zinc are shown (left panel, mean and s.e. of two determinations). These cell lines were seeded similarly in a 96 well dish. Tritiated thymidine was added at 0 or 24 h and thymidine uptake was quantitated 18 h later. Thymidine uptake in the presence of zinc relative to the absence of zinc is shown during the 1st or 2nd days after zinc addition (right panel, mean and s.e. of three determinations). Thymidine uptake in Ba/F3-MTCB6 cells was 36 000 c.p.m. during the 2nd day. (b) 32D cl3, 32D-MTCB6, 32D-MTINV-1, -2, and -3 cells were seeded at 2610 4 cells/ml in the presence or absence of zinc. The increases in cell numbers after 2 or 3 days in the presence of zinc relative to the absence of zinc are shown (left panel, mean and s.e. of three determinations). These cell lines were seeded at a similar concentration in a 96 well dish. Tritiated thymidine was added at 0, 24, or 48 h after zinc addition and thymidine uptake was quantitated during the 1st, 2nd or 3rd days after zinc addition. Thymidine uptake in the presence of zinc relative to the absence of zinc is shown (right panel, mean and s.e. of three determinations). Thymidine uptake in 32D-MTCB6 cells was 17 000 c.p.m. during the 2nd day in the absence of zinc are shown (Figure 6a ). Few cells were detected with sub-2N DNA content (right panels), and zinc did not induce DNA laddering or Annexin V binding in the MTINV lines (data not shown), con®rming the absence of signi®cant ongoing apoptosis.
The proportion of cells in the G1, S, and G2/M cell cycle phases in these cultures were quantitated. Control 32D cl3 or Ba/F3 lines had approximately 30% G1 phase cells, 63% S phase cells, and 7% G2/M phase cells. The ratios of cells in each phase, comparing cells cultured in the presence of zinc with those cultured in its absence, are shown (Figure 6b and c). For 32D cl3 cells, diploid (D) and tetraploid (T) cells were gated separately. Induction of CBFb-SMMHC did not alter the portion of 32D cl3, 32D-MTCB6-1, -2 and -3 cells in S, G1, or G2/M. Analysis of three additional 32D-MTCB6 clones, each in duplicate, gave similar results. However, the proportion of G1-phase cells in the 32D-MTINV subclones increased 1.4 ± 1.7-fold (to 42 ± 51%), and the proportion of S phase cells decreased correspondingly (to 42 ± 49%). Similarly, the cell cycle phase distribution of Ba/F3-MTCB6 cells was not markedly altered by zinc addition, whereas the proportion of G1-phase cells in the Ba/F3-MTINV lines increased 1.5 ± 1.9-fold (to 45 ± 57%), and the proportion of S phase cells decreased 1.3 ± 1.8-fold (to 35 ± 48%). Thus, the ratio of G1 to S cells increased on average 2.6-fold as result of CBFb-SMMHC induction in 32D cl3 myeloid and in Ba/F3 lymphoid cells. The proportion of G2/M cells was not markedly altered. Small changes in the proportion of G2/M cells must be interpreted cautiously, as only 4 ± 8% of cells were present in these cell cycle phases. Results obtained with the tetraploid 32D-MTINV-1 subclone were identical to those obtained with diploid subclones.
CBFb-SMMHC reduced Rb phosphorylation
To determine whether inhibition of the G1 to S transition by CBFb-SMMHC occurred prior to or after the restriction point, the aect of CBFb-SMMHC induction on Rb phosphorylation was assessed in Ba/ F3, Ba/F3-MTCB6, and Ba/F3-INV-2 and -3 cells (Figure 7a ). In both control lines Rb was fully phosphorylated, even after 24 h of culture in 100 mM zinc. Rb was also fully phosphorylated in the INV lines prior to zinc addition. However, 24 h after CBFb-SMMHC induction 50 ± 75% of Rb was hypophosphorylated in the Ba/F3-INV lines. The aect of CBFb-SMMHC on Rb phosphorylation was also assessed in 32D-MTCB6 and 32D-MTINV-1 and -3 cells and in an additional set of Ba/F3-MTCB6 and Ba/F3-MTINV-2 and -3 cells (Figure 7b, top panels) . Approximately, 75% of Rb was fully phosphorylated in 32D-MTCB6 cells, even 24 h after zinc addition, and in 32D-MTINV-1 and -3 cells prior to zinc addition. After CBFb-SMMHC induction 50 ± 75% or Rb was hypophosphorylated in the 32D-MTINV lines. Results with the second set of Ba/F3 cultures con®rmed those obtained in Figure 7a . These same ®lters were stripped and probed with anti-CBFb (bottom panels). Marked induction of CBFb-SMMHC was evident in the INV lines, with the levels obtained in the Ba/F3-INV lines again being higher than in the 32D-INV lines. In contrast to the observed alteration in Rb phosphorylation, induction of CBFb-SMMHC did not signi®cantly alter the levels of phosphorylation of the Rb-related protein p107 (data not shown). 
CBFb-SMMHC did not alter IL-3 Receptor levels
CBFb-SMMHC`knockin' mice predominantly manifest hematopoietic defects, and IL-3 speci®cally stimulates proliferation of marrow progenitors, as well as 32D cl3 and Ba/F3 cells. The eect of CBFb-SMMHC on the expression of the IL-3 Receptor (IL3-R) was therefore evaluated. Total cellular extracts corresponding to equivalent numbers of 32D cl3, 32D-MTCB6, and 32D-MTINV-1 and -3 cells, cultured in the presence or absence of zinc, were subject to Western blotting and probed with antisera speci®c for (Figure 7c , top panels). The murine IL3-Ra subunit has a molecular weight of approximately 70 kd, the murine IL-Rb IL3 glycoprotein migrates near 120 kd, and the more abundant murine IL3-Rb c is larger (Miyajima et al., 1993) . The levels of these subunits were not aected by CBFb-SMMHC induction in 32D cl3 cells. Another hematopoietic protein which regulates the G1 to S transition is c-Myb (Gewirtz et al., 1989) . c-Myb mRNA levels were not aected by CBFb-SMMHC in 32D cl3 cells (data not shown).
To begin to determine the aect of CBFb-SMMHC on intracellular pathways known to regulate Rb phosphorylation, we assessed its eect on p27
Kip1 and p27 WAF1/CIP1 expression. p27 levels were induced approximately twofold by zinc in both control and INV lines (data not shown). p21 levels were not aected by zinc in control lines, but were increased 2 ± 3-fold in 32D-MTINV cells (Figure 7c , bottom panel), a ®nding reproduced in additional experiments. Equivalency of each paired sample (+/7 zinc) in the IL3-R and p21 Western blots is evident from the intensities of the CRM band in the latter blot.
Discussion
CBF plays a central role in hematopoiesis, being required for the establishment of de®nitive hematopoiesis (Okuda et al., 1996a; Wang et al., 1996a,b) and for the expression of both lymphoid and myeloid-speci®c genes (e.g. Redondo et al., 1992; Suzow and Friedman, 1993) . Consistent with the importance of CBF for the growth and maturation of immature blood cells, gene rearrangements involving CBF subunits are commonly found in AML (as recently reviewed, Liu et al., 1995; Nucifora and Rowley, 1995) and in pediatric B-lineage ALL (Golub et al., 1995; Romana et al., 1995) . Remarkably, mice derived from ES cells heterozygous 5 cells were electrophoresed on a 7.5% acrylamide gel, transferred to nitrocellulose and probed with a monoclonal anti-Rb antibody. The positions of fully phosphorylated and hypophosphorylated Rb (Rb-P, Rb) are shown. (b) Proteins were prepared from additional cultures of Ba/F3-MTCB6 and Ba/F3-INV-2 and -3 cells and from 32D-MTCB6 and 32D-MTINV-1 and -3 cells 0 or 24 h after zinc addition. These extracts were analysed similarly for Rb expression (top panels). These blots were stripped and reprobed using anti-CBFb antiserum (bottom panels). The positions of Rb-P, Rb, CBFb-SMMHC, and cross-reactive material (CRM) are indicated. (c) Protein extracts were prepared from 32D cl3, 32D-MTCB6, and 32D-MTINV-1 and -3 cells 0 or 24 h after zinc addition. These extracts were subject to electrophoresis on a 7.5% gel, transferred to nitrocellulose, and probed with either an anti-IL3-Ra antiserum (top panel) or an anti-IL3-Rb antiserum (middle panel). These same extracts were electrophoresed on a 12% acrylamide gel, transferred, and probed with a p21 for CBFb-SMMHC at the CBFb locus or for AML1-ETO at the AML1 locus, displayed the same phenotypes as did CBFb or AML1 null mice, including lack of de®nitive hematopoiesis (Castilla et al., 1996; Okuda et al., 1996b; Yergeau et al., 1997) . Also, AML1-ETO interfered with transactivation by AML1 Frank et al., 1995) , and CBFb-SMMHC inhibited CBF DNA-binding in vitro and in NIH3T3 cells . We have now provided evidence that CBFb-SMMHC can interfere with CBF DNA-binding in hematopoietic cell lines, with partial inhibition evident in 32D cl3 myeloid cells when CBFb-SMMHC was expressed at levels similar to endogenous CBFb. These data together support a unifying hypothesis which states that CBF-related oncoproteins act by inhibiting CBF functions.
CBFb-SMMHC : CBFa complexes are still competent for DNA binding , but have been found capable of sequestering CBFa subunits in multimeric nuclear rod-like or speckled structures Liu et al., 1996) . Formation of these multimers presumably depends upon the SMMHC segment, which normally mediates smooth muscle myosin multimerization (Kiehart, 1990) . We only detected these structures when CBFb-SMMHC was expressed at high levels, by induction with zinc in Ba/F3 cells, perhaps indicating a threshold for their formation. On EMSA, we detected a very slowlymigrating complex in 32D-MTINV extracts, but not in control 32D cl3 extracts. This complex interacted speci®cally with the CBF binding-site. Its level did not increase signi®cantly with zinc addition, perhaps re¯ecting a large excess of CBFb-SMMHC over endogenous CBFa under these conditions. Also, a portion of CBFa bound to CBFb-SMMHC`rods' might be insoluble under our extraction conditions. ES cells lacking AML1 failed to contribute to hematopoiesis in chimeric mice, indicating that the functional hematopoietic defect was cell autonomous (Okuda et al., 1996a) . Herein we provide evidence that this intrinsic cellular defect inhibits, and might even abrogate, G1 to S cell cycle progression. This defect occurs at or prior to the restriction point in G1. Thus, lack of AML1 or expression of CBFb-SMMHC does not result only in reduced expression of E2F or E2F target genes, for example, each of which is required for entry into S phase after E2F family members are released from Rb as a consequence of Rb phosphorylation. Rather, mitogenic signaling events in early G1 are perturbed. Our observations also indicate that neither induction of apoptosis nor abberant differentiation is the primary defect which contributes to the lack of hematopoietic cells in AML1 or CBFb null mice, or in CBFb-SMMHC or AML1-ETO`knock-in' mice. Our ®ndings were similar with both 32D cl3 myeloid cells and Ba/F3 B-lymphoid cells, consistent with the defect in multiple hematopoietic lineages in these mice and with the involvement of CBF oncoproteins in both AML and B-lineage ALL. Of note, expression of AML1-ETO in 32D cl3 cells also slowed their proliferation (S Hiebert, personal communication).
Our suspicion that CBFs regulate a mitogenic protein expressed speci®cally in hematopoietic cells, and the observation that CBF regulates the M-CSF Receptor promoter (Zhang et al., 1994) , led us to evaluate the eect of CBFb-SMMHC induction on the expression of the IL-3 Receptor. Both the IL3-Ra and IL3-Rb subunit levels were unaected. The most proximate regulator of Rb phosphorylation is the cyclinD-cdk4 or -cdk6 complex, which is itself regulated by cyclin inhibitors. We detected a modest increase in one of these inhibitors, p21
, after CBFb-SMMHC induction. Additional experiments will be required to more fully characterize the aect of CBFb-SMMHC on the pathways which regulate Rb phosphorylation during early G1 and to identify the primary genetic target(s) whose expression is(are) reduced as a consequence of CBF inhibition.
32D cl3 and Ba/F3 cells were chosen for these studies as they are both non-leukemic and factordependent, thus resembling normal hematopoietic progenitors to a greater degree than lines derived from human or murine leukemias. 32D cl3 cells in addition retain the ability to dierentiate to neutrophils in response to a natural hormone, G-CSF (Valtieri et al., 1987) . CBFb-SMMHC did not prevent 32D cl3 cells dierentiation. Perhaps sucient CBF activities were retained upon CBFb-SMMHC induction to allow dierentiation. Consistent with these observations, targeted expression of CBFb-SMMHC to the granulocytic lineage in transgenic mice did not prevent the generation of neutrophils, although a qualitative defect in neutrophil functions was observed (S Kogan and JM Bishop, personal communication).
CBFb-SMMHC is present in the associated eosinophilic blasts in the M4eo subtype of AML (Haferlach et al., 1996) . Yet, CBFb-SMMHC did not induce an eosinophilic phenotype in 32D cl3 cells. The cellular target of transformation by CBFb-SMMHC might retain the ability to dierentiate along both the eosinophil and the myeloid pathways.
Accumulated evidence indicates that neither CBFb-SMMHC nor AML1-ETO alone transform hematopoietic cells. Additional genetic`hits', which we predict occur prior to chromosomal alternations leading to activation of CBF oncoproteins, are likely required to bypass inhibition of cell cycle progression by these oncoproteins, as diagrammed in Figure 8 . Perhaps in the presence of these proliferative signals inhibition of CBF function by CBF oncoproteins can be more complete, leading to inhibition of myeloid or lymphoid dierentiation. Consistent with this model, when Kasumi AML cells, which harbor t(8;21), were treated with an AML1-ETO antisense oligonucleotide they dierentiated and their proliferation rate slowed (Sakakura et al., 1994) . The possibility that CBF oncoproteins also contribute to tumor progression or phenotype by activating a subset of gene regulated by CBFs was recently raised by the observation that AML1-ETO can activate the BCL-2 gene promoter (Klampfer et al., 1996) . Again, such gene activation might be potentiated by initial genetic hits which enable higher level expression of AML1-ETO and other CBF oncoproteins.
CBF cooperates with several transcription factors during myeloid dierentiation, including c-Myb, C/ EBP, and PU.1 (Nuchprayoon et al., 1994; OelgeschlaÈ ger et al., 1996; Britos-Bray and Friedman, 1996) , and inhibition of C/EBP activities slowed 32D cl3 cell proliferation in IL3 . Perhaps these factors also cooperate to regulate genes required for the proliferation of primitive hematopoietic cells. Future experiments will aim to identify the genetic targets of CBFb-SMMHC and other CBF oncoproteins relevant to the regulation of cell cycle progression. Human AMLs expressing CBFb-SMMHC or AML1-ETO respond more favorably to chemotherapy than do the majority of AMLs (Hiddemann et al., 1995) , as does pediatric B-lineage ALLs expressing TEL-AML1 when compared with ALLs from other pediatric patients (McLean et al., 1996) . Therefore, these investigations might provide insights which lead to improved therapies for less responsive leukemias.
Materials and methods
Cell culture and transfection 32D cl3 cells (Valtieri et al., 1987) were maintained in Iscove's modi®ed Dulbecco's medium (IMDM) supplemented with 10% (v/v) heat-inactivated fetal calf serum (HI-FCS), penicillin-streptomycin (P-S), and 1 ng/ml recombinant murine IL-3 (R&D Systems, Minneapolis, MN). To induce dierentiation, or for IL-5 addition, the cells were washed twice with phosphate-buered saline (PBS) and then resuspended in IMDM containing 10% (v/v) HI-FCS, P-S, and 1000 U/ml G-CSF (Amgen, Thousand Oaks, CA) or 10 ng/ml recombinant murine IL-5 (R&D Systems, Minneapolis, MN). Ba/F3 cells (Palacios and Steinmetz, 1985) were maintained in RPMI Medium 1640 with 10% HI-FCS, IL-3, and P-S. Viable cell number was determined by enumerating cells which excluded Trypan Blue Dye using a hemocytometer. Morphologic dierentiation was assessed by Wright's-Giemsa staining of cell cytospins as described (Scott et al., 1992) . DNA laddering was detected as described . Annexin V binding was assessed with the ApoAlert Kit (Clontech, Palo Alto, CA). The 1.8 kb cDNA encoding CBFb-SMMHC was subcloned between the KpnI and XbaI sites in the polylinker of pMTCB6 (Braun et al., 1995) to create pMTINV. pMTCB6 or pMTINV were linearized by ScaI digestion, and 15 mg of linearized DNA was electroporated into 5610 6 Ba/F3 or 32D cl3 cells in ice-cold PBS at settings of 300 mV and 960 mF. Transfectants were selected using 1.2 mg/ml G418. Subclones were isolated by limiting dilution and maintained in 0.6 ± 1.2 mg/ml G418. To induce the MT promoter, zinc chloride was added at 50 ± 100 mM.
Western blot analysis and indirect immuno¯uorescence
Total cellular extracts were subject to Western blotting as described (Scott et al., 1992) . Polyclonal rabbit antiserum raised against a CBFb-GST fusion protein (Cameron et al., 1994 ) was employed at a 1 : 1000 dilution as described (Scott et al., 1992) . Rb 14001A and p27 Kip1 13231A monoclonal antibodies (Pharmingen, San Diego, CA), IL3-Ra(V18), IL3-Rb(T20) and p107 (C18) rabbit antisera (Santa Cruz Biotech., Santa Cruz, CA), and p21
Ab-5 rabbit antiserum (Oncogene Res., Cambridge, MA) were employed at 1 : 100. The bands were visualized with an ECL kit (Amersham, Arlington Heights, IL). Filters were stripped for 30 min at 558C in 100 mM b-mercaptoethanol, 2% sodium dodecyl sulfate, 62.5 mM Tris, pH 6.7. The ®lter was then washed twice at 228C with 150 mM NaCl, 50 mM Tris, pH 7.5, 0.3% Tween-20 and reblocked.
For indirect immuno¯uorescence, cells were cytospun onto glass slides and ®xed for 30 min on ice in 4% paraformaldehyde/PBS. Slides were then rinsed with PBT-PBS, 0.2% bovine serum albumin, 0.05% Tween-20-blocked with 5% goat serum in PBT, and incubated with rabbit anti-CBFb peptide antiserum C1, diluted 1 : 500 in PBT . Slides were then washed, incubated with FITCconjugated goat anti-rabbit IgG diluted, 1 : 150 in PBT (Sigma, St Louis, MO), washed, overlayed with 0.1 M npropylgallate with 50% glycerol in PBS, and visualized bȳ uorescent microscopy at 1006.
Nuclear extraction and gel shift analysis
To prepare 32D cl3 nuclear extracts, 3610 7 cells were washed twice with ice-cold PBS and incubated on ice in PBS containing 5 mM diisopropyl¯uorophosphate (DFP, Sigma, St Louis, MO) for 15 min. The cells were then washed again with PBS and resuspended on ice in KNMTS buer (60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 10 mM Tris, pH 7.4, 300 mM sucrose) with 1 mM dithiothreitol (DTT), 2 mM benzamidine, 0.5 mM spermidine, 0.4 mM phenylmethylsulfonyl¯uoride (PMSF), 1% nonfat dried milk (NFDM), leupeptin (10 mg/ml), pepstatin A (1 mg/ml), antipain (1 mg/ml), chymostatin (1 mg/ml), soybean trypsin inhibitor (2 mg/ml), and aprotinin (10 mg/ml). After 5 min Nonidet P-40 was added to 0.05% (v/v). After an additional 5 min the released nuclei were pelleted at 850 g for 5 min, resuspended 1 ml of a similar solution lacking Nonidet P-40, microfuged at 16 000 g for 3 min, and extracted by addition of 0.6 ml of buer C, as described (Dignam et al., 1983) , containing the above concentrations of DTT, benzamidine, spermidine, PMSF, and peptide protease inhibitors. The extracts were rocked at 48C for 30 min, microfuged at 16 000 g for 15 min, aliquoted, snap frozen in liquid nitrogen, and stored at 7808C. Protein concentrations in the extracts were assessed by the Bradford assay (Bio-Rad, Richmond, CA). Nuclear extracts were prepared from Ba/F3 cells similarly, except that the cells were not treated with DFP.
Electrophoretic mobility shift assays (EMSA) with a radiolabeled oligonucleotide containing the murine MPO CBF site were carried out as described (Suzow and Friedman, Figure 8 Model for how additional genetic alterations in acute myeloid and lymphoid leukemias might cooperate with CBF oncoproteins such as CBFb-SMMHC, AML1-ETO, AML1-MDS1, and TEL-AML1. CBF transcription factors activate multiple dierentiation-speci®c genes and at least one gene required for cell cycle progression during early G1 in hematopoietic cells. Reduction of CBF activities by these oncoproteins aects both of these pathways. Initial, proliferative genetic`hits' occur prior to expression of CBF oncoproteins. These mutations by-pass the inhibitory eect of CBF oncoproteins on proliferation, but still allow inhibition of dierentiation. Proliferative mutations might potentiate inhibition of differentiation in these leukemias, by enabling higher level expression of CBF oncoproteins and so a more complete blockade of CBF activities. As dierentiation normally leads to loss of proliferative capacity, decreased dierentiation might itself provide a stimulus to proliferation. Blockade of dierentiation is not absolute, as the majority of leukemic blasts harboring these oncoproteins express dierentiation markers such as MPO. The possibility that CBF oncoproteins activate genes leading to tumor progression, such as the BCL-2 gene (Klampfer et al., 1996) , or partial dierentiation must also be considered 1993). For oligonucleotide competition, unlabeled competitors were added 5 min prior to the radiolabeled probe.
Tritiated thymidine incorporation and BrdU/PI staining
Cells were seeded at 2610 4 cells/ml in duplicate or triplicate in 96 well dishes in the presence or absence of zinc. 0.5 mCi of [ 3 H]thymidine (Dupont NEN, Boston, MA) was added at time zero, 24 h, or 48 h. Eighteen hours after thymidine addition a multiple channel harvester (Brandel, Gaithersburg, MD) was employed to wash the cells 10 times with water on a nylon type 200L membrane (Robbins Scienti®c, Sunnyvale, CA). Incorporated isotope was then counted in a Tricarb liquid scintillation analyser (Packard, Downers Grove, IL).
For BrdU/PI staining, 2610 6 cells in log phase were pulsed for 30 min with 30 mM bromo-deoxyuridine (BrdU, Sigma, St Louis, MO). Cells were then washed twice with IFA buer ± 150 mM NaCl, 10 mM HEPES, pH 7.4, 4% (v/ v) heat-inactivated calf serum ± and ®xed by slow addition of 1 ml of 70% methanol prechilled to 7208C with vortexing. The cells were then suspended in 1 ml of 2 M HCl with 0.2 mg/ml freshly added pepsin (Sigma, St Louis, MO) and incubated for 30 min at 228C. 3 ml of 0.1 M sodium tetraborate was then added, the cells were washed with IFA and with IFA plus 0.5% Tween-20 (IFA-T). The cells were then resuspended in 80 ml IFA-T, and 20 ml of anti-BrdU-FITC (Becton Dickinson, Mountain View, CA) was added for 30 min at 228C. The cells were then washed with IFA-T and incubated for 15 min at 378C in PBS with 100 U/ml DNase-free RNase. Propidium iodide (PI) was then added to 25 mg/ml and the cells were subjected to FACScan analysis with a FACSort apparatus (Becton Dickinson, Mountain View, CA).
Northern blotting
Total cellular RNAs were prepared from 32D cl3 cells and subject to Northern blotting for murine MPO mRNA as described (Friedman et al., 1991) . c-Myb mRNA expression was assessed using a murine c-Myb probe (OelgeschlaÈ ger et al., 1996) .
